Novel antibiofilm chemotherapy targets exopolysaccharide synthesis and stress tolerance in Streptococcus mutans to modulate virulence expression in vivo
about
α-Mangostin disrupts the development of Streptococcus mutans biofilms and facilitates its mechanical removalIn vitro synergism of fosfomycin and clarithromycin antimicrobials against methicillin-resistant Staphylococcus pseudintermediusEfficacy of novel antibacterial compounds targeting histidine kinase YycG protein.Streptococcus mutans, Candida albicans, and the human mouth: a sticky situation.The Effect of Essential Oils and Bioactive Fractions on Streptococcus mutans and Candida albicans Biofilms: A Confocal Analysis.pH-activated nanoparticles for controlled topical delivery of farnesol to disrupt oral biofilm virulence.Removal of Dental Biofilms with an Ultrasonically Activated Water Stream.Triethylene Glycol Up-Regulates Virulence-Associated Genes and Proteins in Streptococcus mutansIn vitro activity of alpha-mangostin in killing and eradicating Staphylococcus epidermidis RP62A biofilms.Targeting of Streptococcus mutans Biofilms by a Novel Small Molecule Prevents Dental Caries and Preserves the Oral Microbiome.Effect of neovestitol-vestitol containing Brazilian red propolis on accumulation of biofilm in vitro and development of dental caries in vivo.Biophysics of biofilm infection.Candida and other fungal species: forgotten players of healthy oral microbiota.SMU.940 regulates dextran-dependent aggregation and biofilm formation in Streptococcus mutans.Efficacy of Miswak toothpaste and mouthwash on cariogenic bacteriaIdentification of anti-biofilm components in Withania somnifera and their effect on virulence of Streptococcus mutans biofilms.The specific degree-of-polymerization of A-type proanthocyanidin oligomers impacts Streptococcus mutans glucan-mediated adhesion and transcriptome responses within biofilms.Identification of linoleic acid, a main component of the n-hexane fraction from Dryopteris crassirhizoma, as an anti-Streptococcus mutans biofilm agent.Biofilm formation by Candida albicans and Streptococcus mutans in the presence of farnesol: a quantitative evaluation.Controlling Streptococcus mutans and Staphylococcus aureus biofilms with direct current and chlorhexidine.Targeting microbial biofilms: current and prospective therapeutic strategies.Effect of tt-farnesol and myricetin on in vitro biofilm formed by Streptococcus mutans and Candida albicans.Inactivation of the spxA1 or spxA2 gene of Streptococcus mutans decreases virulence in the rat caries model.
P2860
Q28544441-E12EEE07-1086-45E2-9948-3BA5CBFB7F98Q33678216-35AD5459-660B-4430-8A72-267E857BCE67Q33755387-CDFF55CA-55BC-465F-938F-A1681801510CQ35022288-6C67E67C-C55E-4564-A6CC-93B364C6C7EAQ35188272-A41393B9-6C2A-4D32-9066-E4E6ADA56753Q35394505-A146C9E3-D3D2-4485-8FB8-A555D90AE035Q35657606-B013BA17-787B-4A25-918A-D71ABC2773C5Q36184472-3899CD97-4452-4BA0-B999-02CD153427F8Q36323203-926895E5-2B98-4F3C-9360-F9632F897FE8Q36389955-4ADC2A12-0900-49CA-A7FC-48E2A40C1740Q37373621-7B2C82F0-C9BC-4728-B86C-371D15058247Q38174582-F4C38FB0-6E8B-4FAC-91D5-D774A1310FD7Q38184339-A507D41A-9D64-4EC7-B40A-0FEE204AAABDQ40078027-20891E34-1D14-4D8B-AFD6-4C9A67FA9F6EQ41202768-74E5C1CA-12BC-45CB-A965-A95B9E15A0E2Q41229713-37471ACE-24F0-4A61-9E60-C0F8A820ADECQ42174670-AD025F60-6CEE-480B-860C-421B3396DCFDQ43521184-1E4209B2-C833-4C85-A3D4-83917ABB5DEAQ46591583-5576AFF4-86A4-49A6-8C8B-933CAC712257Q47105963-97D15A73-F117-426C-9936-2A140F99B99BQ47637669-DCD49BCE-0E67-4AFA-889A-22A2BD68DD65Q49976516-B67743A9-A63E-4283-9E00-13F3FDD611EBQ54906539-E77DF58C-072C-499E-8E43-831AA1AED5B6
P2860
Novel antibiofilm chemotherapy targets exopolysaccharide synthesis and stress tolerance in Streptococcus mutans to modulate virulence expression in vivo
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Novel antibiofilm chemotherapy ...... e virulence expression in vivo
@ast
Novel antibiofilm chemotherapy ...... e virulence expression in vivo
@en
type
label
Novel antibiofilm chemotherapy ...... e virulence expression in vivo
@ast
Novel antibiofilm chemotherapy ...... e virulence expression in vivo
@en
prefLabel
Novel antibiofilm chemotherapy ...... e virulence expression in vivo
@ast
Novel antibiofilm chemotherapy ...... e virulence expression in vivo
@en
P2093
P2860
P356
P1476
Novel antibiofilm chemotherapy ...... e virulence expression in vivo
@en
P2093
Bruno B Silva
José A Lemos
Kathy K Scott-Anne
Marlise I Klein
Megan L Falsetta
Senyo Agidi
P2860
P304
P356
10.1128/AAC.01381-12
P407
P577
2012-09-17T00:00:00Z